Biomarkers and diagnostic tests pipeline

A forum to discuss research on the origins of MS and its development.

Biomarkers and diagnostic tests pipeline

Postby frodo » Tue Jun 05, 2018 5:31 am

The life cycle of the biomarkers is similar to those of the medications. Following is like:

There is a freely available review at [] about the status of knowledge as of 2017, and a wide classification in groups in []

I am gonna try to maintain here a review about some diagnostic tests that are still not in clinical use. Most of them also will serve in the future to monitor the evolution and response to medications:

Advanced MRI technologies

*DTI: MRI that shows Normal Appearing White Matter
*SWI: Susceptibility weighted Imaging: Shows veins, including the central vein of MS lesions.
*MRN: magnetic resonance neurography: Shows damage in peripheral nervous system.

Other imaging technologies

*PET: Positron emission tomography: Can show activated microglia.
*OCT: Optical coherence tomography: Inspection of the eye's retina.

Body Fluid biomarkers

*CSF oligoclonal bands: Currently used in clinical diagnosis
*CSF specific proteins
*MRZ Reaction: Measles Rubeola and Zoster reaction (two positives out of three)
*Light chains (pieces of immunoglobulins) in blood or CSF
*Neurofilament light: [2]
*microRNAs (miRNAs) in blood or CSF: [1][2]. They are associated with "circulated exosomes" (Exosomes are nano-sized particles shed by almost all cell types in the body and are packed with micro-RNAs and other types of small RNA)

In the news:

*micro-RNAs: Nine unique micro-RNA molecules that differentiate between two MS sub-types: relapsing-remitting MS (RRMS) and progressive MS []
*Osteopontin in blood []
User avatar
Family Elder
Posts: 1117
Joined: Wed Dec 02, 2009 4:00 pm


Return to MS Etiology and Pathogenesis


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service